FluoroPharma Medical, Inc. Research and Development Expense
FluoroPharma Medical, Inc. reported Research and Development Expense of $511.38 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2017-03-31
- FluoroPharma Medical, Inc. research and development expense for the quarter ending 2016-12-31 was $103.89K, a 27.87% decline year-over-year.
- FluoroPharma Medical, Inc. research and development expense for the quarter ending 2016-09-30 was -$21.84K, a 107.49% decline year-over-year.
- FluoroPharma Medical, Inc. research and development expense for the quarter ending 2016-06-30 was $239.67K, a 17.81% decline year-over-year.
- FluoroPharma Medical, Inc. research and development expense for the quarter ending 2016-03-31 was $189.66K, a 3.98% increase year-over-year.
- FluoroPharma Medical, Inc. research and development expense for fiscal 2016 was $511.38K, a 29.06% decline from fiscal 2015.
- FluoroPharma Medical, Inc. research and development expense for fiscal 2015 was $720.86K, a 58.89% decline from fiscal 2014.
- FluoroPharma Medical, Inc. research and development expense for fiscal 2014 was $1.75M, a 33.60% increase from fiscal 2013.
- FluoroPharma Medical, Inc. research and development expense for fiscal 2013 was $1.31M, a 7.78% decline from fiscal 2012.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 97 month | Research and Development Expense 100 month | Research and Development Expense 103 month | Research and Development Expense 106 month | Research and Development Expense 109 month | Research and Development Expense 112 month | Research and Development Expense 115 month | Research and Development Expense 118 month | Research and Development Expense 121 month | Research and Development Expense 124 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $103.89K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $82.05K derived: sum of 2 quarters · filed 2017-03-31 | $321.72K derived: sum of 3 quarters · filed 2017-03-31 | $511.38K 10-K · filed 2017-03-31 | |||||||||||
| 2016-09-30 | -$21.84K 10-Q · filed 2016-11-14 | $217.83K derived: sum of 2 quarters · filed 2016-11-14 | $407.49K 10-Q · filed 2016-11-14 | $551.53K derived: sum of 4 quarters · filed 2017-03-31 | |||||||||||
| 2016-06-30 | $239.67K 10-Q · filed 2016-08-15 | $429.33K 10-Q · filed 2016-08-15 | $573.36K derived: sum of 3 quarters · filed 2017-03-31 | $864.98K derived: sum of 4 quarters · filed 2017-03-31 | |||||||||||
| 2016-03-31 | $189.66K 10-Q · filed 2016-05-16 | $333.70K derived: sum of 2 quarters · filed 2017-03-31 | $625.32K derived: sum of 3 quarters · filed 2017-03-31 | $916.93K derived: sum of 4 quarters · filed 2017-03-31 | |||||||||||
| 2015-12-31 | $144.04K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $435.65K derived: sum of 2 quarters · filed 2017-03-31 | $727.27K derived: sum of 3 quarters · filed 2017-03-31 | $720.86K 10-K · filed 2017-03-31 | |||||||||||
| 2015-09-30 | $291.62K 10-Q · filed 2015-11-16 | $583.24K derived: sum of 2 quarters · filed 2016-11-14 | $576.82K 10-Q · filed 2016-11-14 | $1.29M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||
| 2015-06-30 | $291.62K 10-Q · filed 2016-11-14 | $102.80K 10-Q · filed 2015-08-14 | $285.21K 10-Q · filed 2016-08-15 | $994.58K derived: sum of 3 quarters · filed 2016-11-14 | $1.64M derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||
| 2015-03-31 | $182.41K 10-Q · filed 2016-05-16 | $702.97K derived: sum of 2 quarters · filed 2016-05-16 | $1.34M derived: sum of 3 quarters · filed 2016-05-16 | $1.61M derived: sum of 4 quarters · filed 2016-05-16 | |||||||||||
| 2014-12-31 | $520.56K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.16M derived: sum of 2 quarters · filed 2016-03-30 | $1.43M derived: sum of 3 quarters · filed 2016-03-30 | $1.75M 10-K · filed 2016-03-30 | |||||||||||
| 2014-09-30 | $641.45K 10-Q · filed 2015-11-16 | $908.35K derived: sum of 2 quarters · filed 2015-11-16 | $1.23M 10-Q · filed 2015-11-16 | $1.57M derived: sum of 4 quarters · filed 2015-11-16 | |||||||||||
| 2014-06-30 | $266.91K 10-Q · filed 2015-08-14 | $591.49K 10-Q · filed 2015-08-14 | $924.33K derived: sum of 3 quarters · filed 2015-08-14 | $1.25M derived: sum of 4 quarters · filed 2015-08-14 | |||||||||||
| 2014-03-31 | $324.59K 10-Q · filed 2015-05-14 | $657.42K derived: sum of 2 quarters · filed 2015-05-14 | $980.36K derived: sum of 3 quarters · filed 2015-05-14 | $1.35M derived: sum of 4 quarters · filed 2015-05-14 | $7.70M 10-Q · filed 2014-05-15 | ||||||||||
| 2013-12-31 | $332.83K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $655.77K derived: sum of 2 quarters · filed 2015-03-31 | $1.02M derived: sum of 3 quarters · filed 2015-03-31 | $1.31M 10-K · filed 2015-03-31 | $7.38M 10-K · filed 2014-03-25 | ||||||||||
| 2013-09-30 | $322.94K 10-Q · filed 2014-11-19 | $688.48K derived: sum of 2 quarters · filed 2014-11-19 | $979.67K 10-Q · filed 2014-11-19 | $1.50M derived: sum of 4 quarters · filed 2014-11-19 | $7.05M 10-Q · filed 2013-11-14 | ||||||||||
| 2013-06-30 | $365.53K 10-Q · filed 2014-08-14 | $656.73K 10-Q · filed 2014-08-14 | $1.17M derived: sum of 3 quarters · filed 2014-08-14 | $1.52M derived: sum of 4 quarters · filed 2014-08-14 | $6.72M 10-Q · filed 2013-08-19 | ||||||||||
| 2013-03-31 | $291.20K 10-Q · filed 2014-05-15 | $809.34K derived: sum of 2 quarters · filed 2014-05-15 | $1.15M derived: sum of 3 quarters · filed 2014-05-15 | $1.42M derived: sum of 4 quarters · filed 2014-05-15 | $6.36M 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | $518.14K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | $863.01K derived: sum of 2 quarters · filed 2014-03-25 | $1.13M derived: sum of 3 quarters · filed 2014-03-25 | $1.42M 10-K · filed 2014-03-25 | $6.07M 10-K · filed 2013-03-28 | ||||||||||
| 2012-09-30 | $344.87K 10-Q · filed 2013-11-14 | $609.85K derived: sum of 2 quarters · filed 2013-11-14 | $905.14K 10-Q · filed 2013-11-14 | $1.29M derived: sum of 4 quarters · filed 2013-11-14 | $5.55M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $264.98K 10-Q · filed 2013-08-19 | $560.27K 10-Q · filed 2013-08-19 | $945.49K derived: sum of 3 quarters · filed 2013-08-19 | $955.76K derived: sum of 4 quarters · filed 2013-08-19 | $5.20M 10-Q · filed 2012-07-27 | ||||||||||
| 2012-03-31 | $295.30K 10-Q · filed 2013-05-15 | $680.52K derived: sum of 2 quarters · filed 2013-05-15 | $690.79K derived: sum of 3 quarters · filed 2013-05-15 | $936.02K derived: sum of 4 quarters · filed 2013-05-15 | $4.94M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $385.22K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $395.49K derived: sum of 2 quarters · filed 2013-03-28 | $640.73K derived: sum of 3 quarters · filed 2013-03-28 | $640.73K 10-K · filed 2013-03-28 | $4.64M 10-K · filed 2012-03-16 | ||||||||||
| 2011-09-30 | $10.27K 10-Q · filed 2012-11-14 | $255.51K derived: sum of 2 quarters · filed 2012-11-14 | $255.51K 10-Q · filed 2012-11-14 | $4.26M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $245.24K 10-Q · filed 2012-07-27 | $245.24K 10-Q · filed 2012-07-27 | $4.25M 10-Q/A · filed 2011-10-04 | ||||||||||||
| 2010-12-31 | -$25.95K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | -$3.80K derived: sum of 2 quarters · filed 2012-03-16 | $27.85K derived: sum of 3 quarters · filed 2012-03-16 | $44.50K 10-K · filed 2012-03-16 | |||||||||||
| 2010-09-30 | $22.15K 10-Q · filed 2011-11-14 | $53.80K derived: sum of 2 quarters · filed 2011-11-14 | $70.45K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $31.65K 10-Q/A · filed 2011-10-04 | $48.30K 10-Q/A · filed 2011-10-04 |